Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AtriCure, Inc. - Common Stock
(NQ:
ATRC
)
35.08
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AtriCure, Inc. - Common Stock
< Previous
1
2
3
Next >
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?
↗
November 29, 2025
This cardiac device maker focused on atrial fibrillation saw a notable insider sale following a year of flat share performance.
Via
The Motley Fool
Topics
Regulatory Compliance
AtriCure (ATRC) Q3 2025 Earnings Call Transcript
↗
October 30, 2025
AtriCure (ATRC) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
AtriCure Inc (NASDAQ:ATRC) Surpasses Q3 2025 Earnings Estimates and Raises Full-Year Outlook
↗
October 29, 2025
AtriCure's Q3 2025 earnings beat expectations with a narrowed loss and strong revenue growth. The medical device firm also raised its full-year financial outlook.
Via
Chartmill
Topics
Earnings
Earnings Scheduled For October 29, 2025
↗
October 29, 2025
Via
Benzinga
AtriCure (ATRC) Q2 2025 Earnings Call Transcript
↗
August 06, 2025
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For July 29, 2025
↗
July 29, 2025
Via
Benzinga
Earnings Scheduled For April 29, 2025
↗
April 29, 2025
Via
Benzinga
AtriCure Earnings Preview
↗
April 28, 2025
Via
Benzinga
Earnings Scheduled For February 12, 2025
↗
February 12, 2025
Via
Benzinga
Expert Outlook: AtriCure Through The Eyes Of 5 Analysts
↗
February 10, 2025
Via
Benzinga
AtriCure (ATRC) Q2 Revenue Jumps 17%
↗
July 30, 2025
Via
The Motley Fool
Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
↗
July 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
July 29, 2025
Via
Benzinga
What's going on in today's after hours session
↗
July 29, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings)
↗
January 22, 2025
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For AtriCure
↗
December 09, 2024
Via
Benzinga
14 Analysts Assess AtriCure: What You Need To Know
↗
April 30, 2025
Via
Benzinga
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
April 30, 2025
Via
Benzinga
11 Analysts Have This To Say About AtriCure
↗
March 21, 2025
Via
Benzinga
Apple To $183? Here Are 10 Top Analyst Forecasts For Wednesday
↗
January 22, 2025
Via
Benzinga
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
↗
October 30, 2024
Via
Benzinga
Navigating 6 Analyst Ratings For AtriCure
↗
July 31, 2024
Via
Benzinga
Analyst Ratings For AtriCure
↗
July 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 29, 2024
Via
Benzinga
ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024
↗
July 30, 2024
ATRC stock results show that AtriCure met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
↗
June 28, 2024
Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 18, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For AtriCure
↗
May 02, 2024
Via
Benzinga
ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024
↗
May 01, 2024
ATRC stock results show that AtriCure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.